Immunovative Therapies, Ltd.
Records under this name other than patents Immunovative Therapies, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Immunovative Therapies, Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,865,224 | Allogeneic cellular immunotherapy for opportunistic infection Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,272,001 | Ablative immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,320,794 | Ablative immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,160,852 | Method of vaccinating using allogeneic cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,972,594 | Ablative immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,751,372 | Vaccine compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,744,158 | Th1 vaccination priming for active immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,695,397 | Th1 vaccination priming for active immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,385,315 | Cells expressing Th1 characteristics and cytolytic properties Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,233,156 | Induction of IL-12 using immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record |